In Stage 1 of the DHA program, the teams will spend the next six months intensively driving the realization of their Digital Health product ideas through need, technology, and market validation.
The following projects are newly funded in DHA Stage 1:
Dr. Federico Collettini, Department of Radiology, Charité: Wearable Solution for the Early Detection of Acute and Critical Limb Ischemia in Patients With Peripheral Artery Disease
PD Dr. Katharina Erb-Eigner, Department of Radiology, Charité: Autopilot for Identifying Rare and Atypical Diseases
Prof. Dr. Tabea Viktoria Flügge, Clinic for Oral and Maxillofacial Surgery, Charité: Digital Platform for the Early Detection of Oral Pathologies and Telemedical Support
Dr. Laura Hatzler, Institute for Sexual Science and Sexual Medicine, Charité: Multimodal E-Health Solution for Personalized Medicine in Women's Sexual Health
Iris Wing To, Lam/ Dr. Susanne Holzhauer, Clinic for Pediatrics m.S. Oncology and Hematology/ Medical Clinic m. S. Infectiology and Pneumology, Charité: Portable Blood Analysis Solution for Personalized Medicine
PD Dr. Lena Oevermann, Dr. Jonathan Groß, Clinic for Pediatrics m.S. Oncology and Hematology, Charité: Matching and Prediction Tool for Risk of Graft-Versus-Host Disease
Dr. Miriam Sebold, Department of Psychiatry and Psychotherapy, Charité: Virtual Reality-based Therapy for Alcohol Use Disorder.
Together with 11 projects in DHA Stage 2, the BIH DHA program thus currently supports 18 project teams developing Digital Health products. In addition to funding, support includes professional mentoring by international experts, access to development partners and talent, networks with industry and investors, and an interdisciplinary working environment in the BIH Digital Labs Co-working Space in close proximity to the Charité Campus Mitte. So far, five spin-offs have resulted from the DHA program. More information on the BIH DHA program: https://www.bihealth.org/en/digital-health-accelerator.
BIH wishes the teams every success with their translation projects.